1
Clinical Trials associated with AV2-DMSingle Center, Placebo Controlled, Double-Blind Study to the Treatment of HPV Infected Cervix With AV2 Antiviral Spray and Assessment of Viral Load
This study aims to prove that, by a one-time topical spray on the cervix, AV2-DM is an effective antiviral in reducing on short term (3 months) the human papillomavirus (HPV) infection.
Primary endpoint: significant drop in viral load AV2-DM versus placebo
Secondary endpoint:the number of patients with adverse events
100 Clinical Results associated with AV2-DM
100 Translational Medicine associated with AV2-DM
100 Patents (Medical) associated with AV2-DM
100 Deals associated with AV2-DM